Cargando…

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization

BACKGROUND: Memantine, drug approved for moderate to severe Alzheimer’s disease, has not shown to be fully effective. In order to solve this issue, polylactic-co-glycolic (PLGA) nanoparticles could be a suitable solution to increase drug’s action on the target site as well as decrease adverse effect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-López, Elena, Ettcheto, Miren, Egea, Maria Antonia, Espina, Marta, Cano, Amanda, Calpena, Ana Cristina, Camins, Antoni, Carmona, Nuria, Silva, Amélia M., Souto, Eliana B., García, Maria Luisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870370/ https://www.ncbi.nlm.nih.gov/pubmed/29587747 http://dx.doi.org/10.1186/s12951-018-0356-z

Ejemplares similares

Development of Peptide Targeted PLGA-PEGylated Nanoparticles Loading Licochalcone-A for Ocular Inflammation
por: Galindo, Ruth, et al.
Publicado: (2022)

Lipid Nanoparticles for the Posterior Eye Segment
por: Bonilla, Lorena, et al.
Publicado: (2021)

Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges
por: Bonilla, Lorena, et al.
Publicado: (2021)

Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
por: Cano, Amanda, et al.
Publicado: (2019)

Dexibuprofen Biodegradable Nanoparticles: One Step Closer towards a Better Ocular Interaction Study
por: Sánchez-López, Elena, et al.
Publicado: (2020)

Role of hydroxypropyl-β-cyclodextrin on freeze-dried and gamma-irradiated PLGA and PLGA–PEG diblock copolymer nanospheres for ophthalmic flurbiprofen delivery
por: Vega, Estefanía, et al.
Publicado: (2012)

Current Applications of Nanoemulsions in Cancer Therapeutics
por: Sánchez-López, Elena, et al.
Publicado: (2019)

State of the Art on Toxicological Mechanisms of Metal and Metal Oxide Nanoparticles and Strategies to Reduce Toxicological Risks
por: García-Torra, Victor, et al.
Publicado: (2021)

State-of-the-art polymeric nanoparticles as promising therapeutic tools against human bacterial infections
por: Cano, Amanda, et al.
Publicado: (2020)

Advanced Formulation Approaches for Ocular Drug Delivery: State-Of-The-Art and Recent Patents
por: Souto, Eliana B., et al.
Publicado: (2019)

Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease
por: Ettcheto, Miren, et al.
Publicado: (2019)

Memantine for the Treatment of Dementia: A Review on its Current and Future Applications
por: Folch, Jaume, et al.
Publicado: (2018)

In Vitro Cytotoxicity of Oleanolic/Ursolic Acids-Loaded in PLGA Nanoparticles in Different Cell Lines
por: Silva, Amélia M., et al.
Publicado: (2019)

Thymol-loaded PLGA nanoparticles: an efficient approach for acne treatment
por: Folle, Camila, et al.
Publicado: (2021)

Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer's disease
por: Rabieipoor, Saghar, et al.
Publicado: (2023)

Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
por: Sánchez-López, Elena, et al.
Publicado: (2020)

Nanomedicine-based technologies and novel biomarkers for the diagnosis and treatment of Alzheimer’s disease: from current to future challenges
por: Cano, Amanda, et al.
Publicado: (2021)

Exosomes-Based Nanomedicine for Neurodegenerative Diseases: Current Insights and Future Challenges
por: Cano, Amanda, et al.
Publicado: (2023)

PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer’s disease: in vitro and in vivo studies
por: Silva-Abreu, Marcelle, et al.
Publicado: (2018)

Metformin a Potential Pharmacological Strategy in Late Onset Alzheimer’s Disease Treatment
por: Poor, Saghar Rabiei, et al.
Publicado: (2021)

PEGylated apoptotic protein-loaded PLGA microspheres for cancer therapy
por: Byeon, Hyeong Jun, et al.
Publicado: (2015)

Development, optimization, and evaluation of PEGylated brucine-loaded PLGA nanoparticles
por: Elsewedy, Heba S., et al.
Publicado: (2020)

Development of Lactoferrin-Loaded Liposomes for the Management of Dry Eye Disease and Ocular Inflammation
por: López-Machado, Ana, et al.
Publicado: (2021)

Licochalcone A: A Potential Multitarget Drug for Alzheimer’s Disease Treatment
por: Olloquequi, Jordi, et al.
Publicado: (2023)

The Involvement of Peripheral and Brain Insulin Resistance in Late Onset Alzheimer’s Dementia
por: Folch, Jaume, et al.
Publicado: (2019)

Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles
por: Ashour, Abdelkader E, et al.
Publicado: (2019)

Current Research Therapeutic Strategies for Alzheimer's Disease Treatment
por: Folch, Jaume, et al.
Publicado: (2016)

Extracellular vesicles, the emerging mirrors of brain physiopathology
por: Cano, Amanda, et al.
Publicado: (2023)

Passively Targeted Curcumin-Loaded PEGylated PLGA Nanocapsules for Colon Cancer Therapy In Vivo
por: Klippstein, Rebecca, et al.
Publicado: (2015)

A novel rhein-huprine hybrid ameliorates disease-modifying properties in preclinical mice model of Alzheimer’s disease exacerbated with high fat diet
por: Espinosa-Jiménez, Triana, et al.
Publicado: (2023)

Cytotoxic Evaluation of (2S)-5,7-Dihydroxy-6-prenylflavanone Derivatives Loaded PLGA Nanoparticles against MiaPaCa-2 Cells
por: Andrade-Carrera, Berenice, et al.
Publicado: (2017)

Design, Formulation and in vivo Evaluation of Novel Honokiol-Loaded PEGylated PLGA Nanocapsules for Treatment of Breast Cancer
por: Haggag, Yusuf A, et al.
Publicado: (2020)

Fabrication of curcumin-loaded magnetic PEGylated-PLGA nanocarriers tagged with GRGDS peptide for improving anticancer activity
por: Senturk, Fatih, et al.
Publicado: (2023)

Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways
por: Ettcheto, Miren, et al.
Publicado: (2017)

Benzodiazepines and Related Drugs as a Risk Factor in Alzheimer's Disease Dementia
por: Ettcheto, Miren, et al.
Publicado: (2020)

Dexibuprofen ameliorates peripheral and central risk factors associated with Alzheimer’s disease in metabolically stressed APPswe/PS1dE9 mice
por: Ettcheto, Miren, et al.
Publicado: (2021)

The Implication of the Brain Insulin Receptor in Late Onset Alzheimer’s Disease Dementia
por: Folch, Jaume, et al.
Publicado: (2018)

Diclofenac Loaded Biodegradable Nanoparticles as Antitumoral and Antiangiogenic Therapy
por: Esteruelas, Gerard, et al.
Publicado: (2022)

Peroxisomal Proliferator-Activated Receptor β/δ Deficiency Induces Cognitive Alterations
por: Espinosa-Jiménez, Triana, et al.
Publicado: (2022)

Therapy of addition for Alzheimer's Disease: combination with galantamine and memantine
por: Zarra, Julio, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_spdmsm5l055nilmfsutndnpfa9